RIO DE JANEIRO, Dec 28 (Reuters) - Brazil's Fiocruz
biomedical institute will seek approval for the Oxford
University/AstraZeneca vaccine against COVID-19 with
federal health regulator Anvisa on Jan. 15, one of the center's
senior officials told Reuters on Monday.
The Rio de Janeiro-based institute is licensed to receive
supplies from AstraZeneca and eventually produce the vaccine
locally. Brazil's federal government, which has ordered the
AstraZeneca vaccine, expects to receive 100 million doses in the
first half of 2021.
(Reporting by Pedro Fonseca)
Astrazeneca (AZN)
